Seminars in Nuclear Medicine
Volume 36, Issue 2 , Pages 157-168 , April 2006

Positron Emission Tomography/Computed Tomography: Protocol Issues and Options

References 

  1. Meltzer CC , Luketich JD , Friedman D , et al.   Whole-body FDG positron emission tomographic imaging for staging esophageal cancer comparison with computed tomography . Clin Nucl Med . 2000;25:882–887
  2. Martinelli M , Townsend D , Meltzer C , et al.   Survey of results of whole body imaging using the PET/CT at the University of Pittsburgh Medical Center PET facility . Clin Positron Imaging . 2000;3:161
  3. Kluetz PG , Meltzer CC , Villemagne VL , et al.   Combined PET/CT imaging in oncology. Impact on patient management . Clin Positron Imaging . 2000;3:223–230
  4. Kluetz P , Villemagne VV , Meltzer C , et al.   20. The Case for PET/CT. Experience at the University of Pittsburgh . Clin Positron Imaging . 2000;3:174
  5. Beyer T , Townsend DW , Brun T , et al.   A combined PET/CT scanner for clinical oncology . J Nucl Med . 2000;41:1369–1379
  6. Beyer T , Antoch G , Muller S , et al.   Acquisition protocol considerations for combined PET/CT imaging . J Nucl Med . 2004;45(suppl 1):25S–35S
  7. Antoch G , Freudenberg LS , Beyer T , et al.   To enhance or not to enhance? 18F-FDG and CT contrast agents in dual-modality 18F-FDG PET/CT . J Nucl Med . 2004;45(suppl 1):56S–65S
  8. Antoch G , Freudenberg LS , Stattaus J , et al.   Whole-body positron emission tomography-CT (Optimized CT using oral and IV contrast materials) . AJR Am J Roentgenol . 2002;179:1555–1560
  9. Beyer T , Antoch G , Bockisch A , Stattaus J . Optimized intravenous contrast administration for diagnostic whole-body 18F-FDG PET/CT . J Nucl Med . 2005;46:429–435
  10. Beyer T , Antoch G , Blodgett T , et al.   Dual-modality PET/CT imaging (the effect of respiratory motion on combined image quality in clinical oncology) . Eur J Nucl Med Mol Imaging . 2003;30:588–596
  11. Baron RL , Oliver JH , Dodd GD , et al.   Hepatocellular carcinoma (evaluation with biphasic, contrast-enhanced, helical CT) . Radiology . 1996;199:505–511
  12. Birnbaum BA , Jacobs JE , Ramchandani P . Multiphasic renal CT (comparison of renal mass enhancement during the corticomedullary and nephrographic phases) . Radiology . 1996;200:753–758
  13. Birnbaum BA , Jacobs JE , Yin D . Hepatic enhancement during helical CT (A comparison of moderate rate uniphasic and biphasic contrast injection protocols) . AJR Am J Roentgenol . 1995;165:853–858
  14. Blake SP , Weisinger K , Atkins MB , et al.   Liver metastases from melanoma (Detection with multiphasic contrast-enhanced CT) . Radiology . 1999;213:92–96
  15. Brancatelli G , Federle MP , Grazioli L , et al.   Focal nodular hyperplasia (CT findings with emphasis on multiphasic helical CT in 78 patients) . Radiology . 2001;219:61–68
  16. Bressler EL , Alpern MB , Glazer GM , et al.   Hypervascular hepatic metastases (CT evaluation) . Radiology . 1987;162:49–51
  17. Cohan RH , Sherman LS , Korobkin M , et al.   Renal masses (Assessment of corticomedullary-phase and nephrographic-phase CT scans) . Radiology . 1995;196:445–451
  18. DuBrow RA , David CL , Libshitz HI , et al.   Detection of hepatic metastases in breast cancer (the role of nonenhanced and enhanced CT scanning) . J Comput Assist Tomogr . 1990;14:366–369
  19. Foley WD , Berland LL , Lawson TL , et al.   Contrast enhancement technique for dynamic hepatic computed tomographic scanning . Radiology . 1983;147:797–803
  20. Foley WD , Mallisee TA , Hohenwalter MD , et al.   Multiphase hepatic CT with a multirow detector CT scanner . Am J Roentgenol . 2000;175:679–685
  21. Garrett PR , Meshkov SL , Perlmutter GS . Oral contrast agents in CT of the abdomen . Radiology . 1984;153:545–546
  22. Grazioli L , Federle MP , Brancatelli G , et al.   Hepatic adenomas (Imaging and pathologic findings) . Radiographics . 2001;21:877–892
  23. Hanninen EL , Vogl TJ , Felfe R , et al.   Detection of focal liver lesions at biphasic spiral ct (randomized double-blind study of the effect of iodine concentration in contrast materials) . Radiology . 2000;216:403–409
  24. Heiken JP , Brink JA , McClennan BL , et al.   Dynamic contrast-enhanced CT of the liver (Comparison of contrast medium injection rates and uniphasic and biphasic injection protocols) . Radiology . 1993;187:327–331
  25. Herts BR , Coll DM , Novick AC , et al.   Enhancement characteristics of papillary renal neoplasms revealed on triphasic helical CT of the kidneys . Am J Roentgenol . 2002;178:367–372
  26. Israel GM , Bosniak MA . How I do it (Evaluating renal masses) . Radiology . 2005;236:441–450
  27. Kamel IR , Choti MA , Horton KM , et al.   Surgically staged focal liver lesions (Accuracy and reproducibility of dual-phase helical CT for detection and characterization) . Radiology . 2003;227:752–757
  28. Keogan MT , McDermott VG , Paulson EK , et al.   Pancreatic malignancy (Effect of dual-phase helical CT in tumor detection and vascular opacification) . Radiology . 1997;205:513–518
  29. Kopka L , Funke M , Fischer U , et al.   Parenchymal liver enhancement with bolus-triggered helical CT (Preliminary clinical results) . Radiology . 1995;195:282–284
  30. Lu DS , Vedantham S , Krasny RM , et al.   Two-phase helical CT for pancreatic tumors (pancreatic versus hepatic phase enhancement of tumor, pancreas, and vascular structures) . Radiology . 1996;199:697–701
  31. Oliver JH , Baron RL . Helical biphasic contrast-enhanced CT of the liver (Technique, indications, interpretation, and pitfalls) . Radiology . 1996;201:1–14
  32. Sheafor DH , Keogan MT , DeLong DM , et al.   Dynamic helical CT of the abdomen (prospective comparison of pre- and postprandial contrast enhancement) . Radiology . 1998;206:359–363
  33. Silverman PM , Roberts SC , Ducic I , et al.   Assessment of a technology that permits individualized scan delays on helical hepatic CT (A technique to improve efficiency in use of contrast material) . AJR Am J Roentgenol . 1996;167:79–84
  34. Szolar DH , Kammerhuber F , Altziebler S , et al.   Multiphasic helical CT of the kidney (increased conspicuity for detection and characterization of small (< 3-cm) renal masses) . Radiology . 1997;202:211–217
  35. Vignaux O , Legmann P , Coste J , et al.   Cirrhotic liver enhancement on dual-phase helical CT (Comparison with noncirrhotic livers in 146 patients) . AJR Am J Roentgenol . 1999;173:1193–1197
  36. Brix G , Lechel U , Glatting G , et al.   Radiation exposure of patients undergoing whole-body dual-modality 18F-FDG PET/CT examinations . J Nucl Med . 2005;46:608–613
  37. Yau YY , Chan WS , Tam YM , et al.   Application of intravenous contrast in PET/CT (Does it really introduce significant attenuation correction error?) . J Nucl Med . 2005;46:283–291
  38. Ravizzini G , Nguyen M , Schuster DM , et al.   Central line injection artifact simulating paratracheal adenopathy on FDG PET imaging . Clin Nucl Med . 2004;29:735–737
  39. Goerres GW , Hany TF , Kamel E , et al.   Head and neck imaging with PET and PET/CT (artefacts from dental metallic implants) . Eur J Nucl Med Mol Imaging . 2002;29:367–370
  40. Antoch G , Freudenberg LS , Egelhof T , et al.   Focal tracer uptake (a potential artifact in contrast-enhanced dual-modality PET/CT scans) . J Nucl Med . 2002;43:1339–1342
  41. Blodgett T , Fukui MB , Snyderman CH , et al.   Combined PET-CT in the head and neck: Part I. Physiologic, altered physiologic, and artifactual FDG uptake . Radiographics . 2005;25:897–912
  42. Bockisch A , Beyer T , Antoch G , et al.   Positron emission tomography/computed tomography—imaging protocols, artifacts, and pitfalls . Mol Imaging Biol . 2004;6:188–199
  43. Antoch G , Kuehl H , Kanja J , et al.   Dual-modality PET/CT scanning with negative oral contrast agent to avoid artifacts (Introduction and evaluation) . Radiology . 2004;230:879–885
  44. Nehmeh SA , Erdi YE , Kalaigian H , et al.   Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT . J Nucl Med . 2003;44:1940–1944
  45. Cohade C , Wahl RL . Applications of positron emission tomography/computed tomography image fusion in clinical positron emission tomography-clinical use, interpretation methods, diagnostic improvements . Semin Nucl Med . 2003;33:228–237
  46. Visvikis D , Costa DC , Croasdale I , et al.   CT-based attenuation correction in the calculation of semi-quantitative indices of [18F]FDG uptake in PET . Eur J Nucl Med Mol Imaging . 2003;30:344–353
  47. Cohade C , Osman M , Nakamoto Y , et al.   Initial experience with oral contrast in PET/CT (Phantom and clinical studies) . J Nucl Med . 2003;44:412–416
  48. Dizendorf EV , Treyer V , Von Schulthess GK , et al.   Application of oral contrast media in coregistered positron emission tomography-CT . AJR Am J Roentgenol . 2002;179:477–481
  49. Carney JP , Beyer T , Brasse D , et al.   Clinical PET/CT scanning using oral CT contrast agents . J Nucl Med . 2002;45:57
  50. de Juan R , Seifert B , Berthold T , et al.   Clinical evaluation of a breathing protocol for PET/CT . Eur Radiol . 2004;14:1118–1123
  51. Goerres GW , Burger C , Schwitter MR , et al.   PET/CT of the abdomen (Optimizing the patient breathing pattern) . Eur Radiol . 2003;13:734–739
  52. Osman MM , Cohade C , Nakamoto Y , et al.   Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT . Eur J Nucl Med Mol Imaging . 2003;30:603–606
  53. Romer W , Chung M , Chan A , et al.   Single-detector helical CT in PET-CT (Assessment of image quality) . AJR Am J Roentgenol . 2004;182:1571–1577
  54. Osman MM , Cohade C , Nakamoto Y , et al.   Clinically significant inaccurate localization of lesions with PET/CT (frequency in 300 patients) . J Nucl Med . 2003;44:240–243
  55. Coleman RE , Delbeke D , Guiberteau MJ , et al.   Concurrent PET/CT with an integrated imaging system (intersociety dialogue from the joint working group of the American College of Radiology, the Society of Nuclear Medicine, and the Society of Computed Body Tomography and Magnetic Resonance) . J Nucl Med . 2005;46:1225–1239

PII: S0001-2998(05)00073-5

doi: 10.1053/j.semnuclmed.2005.12.004

Seminars in Nuclear Medicine
Volume 36, Issue 2 , Pages 157-168 , April 2006